{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:43:37Z","timestamp":1771919017093,"version":"3.50.1"},"reference-count":39,"publisher":"Impact Journals, LLC","issue":"87","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,11,6]]},"DOI":"10.18632\/oncotarget.23200","type":"journal-article","created":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T19:32:19Z","timestamp":1513193539000},"page":"35780-35789","source":"Crossref","is-referenced-by-count":7,"title":["Bloodstream infection due to <i>Escherichia coli<\/i> in liver cirrhosis patients: clinical features and outcomes"],"prefix":"10.18632","volume":"9","author":[{"given":"Bo","family":"Tu","sequence":"first","affiliation":[{"name":"Center for Infectious Disease, Beijing 302 Hospital, Beijing 100039, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingfeng","family":"Bi","sequence":"additional","affiliation":[{"name":"Center for Clinical Research Management, Beijing 302 Hospital, Beijing 100039, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Wu","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease, Beijing 302 Hospital, Beijing 100039, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhao","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease, Beijing 302 Hospital, Beijing 100039, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Shi","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease, Beijing 302 Hospital, Beijing 100039, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangxin","family":"Xie","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease, Beijing 302 Hospital, Beijing 100039, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease, Beijing 302 Hospital, Beijing 100039, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Xu","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease, Beijing 302 Hospital, Beijing 100039, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suxia","family":"Liu","sequence":"additional","affiliation":[{"name":"Center for Liver Failure, Beijing 302 Hospital, Beijing 100039, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinhua","family":"Wang","sequence":"additional","affiliation":[{"name":"Center for Obstetrics and Gynecology, Beijing 302 Hospital, Beijing 100039, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxi","family":"Li","sequence":"additional","affiliation":[{"name":"Center for Clinical Laboratory, Beijing 302 Hospital, Beijing 100039, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fusheng","family":"Wang","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease, Beijing 302 Hospital, Beijing 100039, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enqiang","family":"Qin","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease, Beijing 302 Hospital, Beijing 100039, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,12,13]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.lfs.2016.01.037","article-title":"Hepatic IGF-1R overexpression combined with the activation of GSK-3beta and FOXO3a in the development of liver cirrhosis","volume":"147","author":"E","year":"2016","journal-title":"Life Sci"},{"key":"2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4254\/wjh.v8.i4.207","article-title":"Inflammasome activation in decompensated liver cirrhosis","volume":"8","author":"Gonzalez-Navajas","year":"2016","journal-title":"World J Hepatol"},{"key":"3","doi-asserted-by":"crossref","first-page":"19903","DOI":"10.1038\/srep19903","article-title":"A profile of volatile organic compounds in exhaled air as a potential non-invasive biomarker for liver cirrhosis","volume":"6","author":"van Schooten","year":"2016","journal-title":"Sci Rep"},{"key":"4","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ccc.2015.06.009","article-title":"Acute Kidney Injury in Cirrhosis","volume":"31","author":"Nadim","year":"2015","journal-title":"Crit Care Clin"},{"key":"5","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/liv.13087","article-title":"Resistance to thrombomodulin is associated with de novo portal vein thrombosis and low survival in patients with cirrhosis","volume":"36","author":"Primignani","year":"2016","journal-title":"Liver Int"},{"key":"6","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0168-8278(12)60002-6","article-title":"Management of bacterial infections in cirrhosis","volume":"56","author":"Gustot","year":"2012","journal-title":"J Hepatol"},{"key":"7","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jhep.2014.01.024","article-title":"Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013","volume":"60","author":"Wilmer","year":"2014","journal-title":"J Hepatol"},{"key":"8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s15010-015-0794-6","article-title":"Epidemiological characteristics of bloodstream infections in patients with different degrees of liver disease","volume":"43","author":"Seminari","year":"2015","journal-title":"Infection"},{"key":"9","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1053\/j.gastro.2010.06.019","article-title":"Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis","volume":"139","author":"Burroughs","year":"2010","journal-title":"Gastroenterology"},{"key":"10","first-page":"61","article-title":"Nosocomial bloodstream infection","volume":"20","author":"Mer","year":"2005","journal-title":"S Afr J Infect Dis"},{"key":"11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-0032-1301737","article-title":"Infectious complications of acute and chronic liver disease","volume":"33","author":"Stadlbauer","year":"2012","journal-title":"Semin Respir Crit Care Med"},{"key":"12","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1086\/317494","article-title":"Population-based study of the risk and short-term prognosis for bacteremia in patients with liver cirrhosis","volume":"31","author":"Tage-Jensen","year":"2000","journal-title":"Clin Infect Dis"},{"key":"13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/21505594.2016.1141162","article-title":"Bloodstream infections in patients with liver cirrhosis","volume":"7","author":"Viale","year":"2016","journal-title":"Virulence"},{"key":"14","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/j.1572-0241.2003.07475.x","article-title":"Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension","volume":"98","author":"Bjornsson","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"15","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance","volume":"61","author":"Alvarez-Mon","year":"2014","journal-title":"J Hepatol"},{"key":"16","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3906\/sag-1303-41","article-title":"Assessment of bloodstream infections and risk factors in an intensive care unit","volume":"45","author":"Baydar","year":"2015","journal-title":"Turk J Med Sci"},{"key":"17","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/1469-0691.12607","article-title":"External validation of bloodstream infection mortality risk score in a population-based cohort","volume":"20","author":"Baddour","year":"2014","journal-title":"Clin Microbiol Infec"},{"key":"18","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1128\/AAC.00627-10","article-title":"Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis","volume":"54","author":"Leibovici","year":"2010","journal-title":"Antimicrob Agents Ch"},{"key":"19","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1128\/AAC.00462-11","article-title":"Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis","volume":"56","author":"Arroyo","year":"2012","journal-title":"Antimicrob Agents Ch"},{"key":"20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Stelling","year":"2012","journal-title":"Clin Microbiol Infec"},{"key":"21","doi-asserted-by":"crossref","first-page":"916","DOI":"10.4254\/wjh.v7.i7.916","article-title":"Multiresistant bacterial infections in liver cirrhosis: Clinical impact and new empirical antibiotic treatment policies","volume":"7","author":"Acevedo","year":"2015","journal-title":"World J Hepatol"},{"key":"22","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Williams","year":"1973","journal-title":"The British journal of surgery"},{"key":"23","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kim","year":"2001","journal-title":"Hepatology"},{"key":"24","volume-title":"Performance standarts for antimicrobial 335 susceptibility testing","author":"Clinical and Laboratory Standart Institute","year":"2012"},{"key":"25","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3904\/kjim.2014.152","article-title":"Bleeding complications in critically ill patients with liver cirrhosis","volume":"31","author":"Lee","year":"2016","journal-title":"Korean J Intern Med"},{"key":"26","doi-asserted-by":"crossref","first-page":"15499","DOI":"10.3748\/wjg.v20.i42.15499","article-title":"Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects","volume":"20","author":"Bendtsen","year":"2014","journal-title":"World J Gastroentero"},{"key":"27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/jpids\/piu073","article-title":"Quantifying the Burden of Hospital-Acquired Bloodstream Infection in Children in England by Estimating Excess Length of Hospital Stay and Mortality Using a Multistate Analysis of Linked, Routinely Collected Data","volume":"4","author":"Deeny","year":"2015","journal-title":"J Pediatric Infect Dis Soc"},{"key":"28","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.ajic.2014.05.033","article-title":"Clinical effect of a multidisciplinary team approach to the initial treatment of patients with hospital-acquired bloodstream infections at a Japanese university hospital","volume":"42","author":"Masada","year":"2014","journal-title":"Am J Infect Control"},{"key":"29","doi-asserted-by":"crossref","first-page":"e104702","DOI":"10.1371\/journal.pone.0104702","article-title":"Characteristics of hospital-acquired and community-onset blood stream infections, South-East Austria","volume":"9","author":"Krause","year":"2014","journal-title":"PloS one"},{"key":"30","doi-asserted-by":"crossref","first-page":"412","DOI":"10.21149\/spm.v57i5.7621","article-title":"Risk factors for extended-spectrum beta-lactamases-producing Escherichia coli urinary tract infections in a tertiary hospital","volume":"57","author":"Santos-Preciado","year":"2015","journal-title":"Salud Publica Mex"},{"key":"31","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3109\/00365548.2013.775479","article-title":"Outcomes and risk factors for mortality in community-onset bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli, with a special emphasis on antimicrobial therapy","volume":"45","author":"Song","year":"2013","journal-title":"Scand J Infect Dis"},{"key":"32","first-page":"165","article-title":"Vital signs: carbapenem-resistant Enterobacteriaceae","volume":"62","author":"Bulens","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"33","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.ajic.2016.03.029","article-title":"Carbapenem-resistant Enterobacteriaceae and endoscopy: An evolving threat","volume":"44","author":"Safdar","year":"2016","journal-title":"Am J Infect Control"},{"key":"34","first-page":"3961684","article-title":"Infections due to Carbapenem Resistant Enterobacteriaceae among Saudi Arabian Hospitalized Patients: A Matched Case-Control Study","volume":"2016","author":"Abushaheen","year":"2016","journal-title":"Biomed Res Int"},{"key":"35","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1055\/s-2008-1040325","article-title":"Assessment of prognosis of cirrhosis","volume":"28","author":"Valla","year":"2008","journal-title":"Semin Liver Dis"},{"key":"36","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/MD.0b013e318210504c","article-title":"Community-acquired pneumonia in patients with liver cirrhosis: clinical features, outcomes, and usefulness of severity scores","volume":"90","author":"Carratala","year":"2011","journal-title":"Medicine"},{"key":"37","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1002\/hep.21920","article-title":"Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure","volume":"46","author":"Moreau","year":"2007","journal-title":"Hepatology"},{"key":"38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jhep.2014.03.021","article-title":"Epidemiology and outcomes of bloodstream infection in patients with cirrhosis","volume":"61","author":"Viale","year":"2014","journal-title":"J Hepatol"},{"key":"39","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/hep.23500","article-title":"Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study","volume":"51","author":"Vilstrup","year":"2010","journal-title":"Hepatology"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.23200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T19:52:51Z","timestamp":1589053971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.23200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,13]]},"references-count":39,"journal-issue":{"issue":"87","published-print":{"date-parts":[[2018,11,6]]}},"alternative-id":["23200","30515269"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.23200","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,13]]}}}